Survival: the relevant primary outcome for nutrition therapy in cancer patients

Curr Opin Clin Nutr Metab Care. 2012 May;15(3):211-2. doi: 10.1097/MCO.0b013e328352dc41.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Docosahexaenoic Acids / therapeutic use
  • Eicosapentaenoic Acid / therapeutic use
  • Humans
  • Muscle, Skeletal / metabolism
  • Muscle, Skeletal / pathology
  • Myostatin / antagonists & inhibitors
  • Myostatin / metabolism
  • Neoplasms / diet therapy*
  • Treatment Outcome

Substances

  • Myostatin
  • Docosahexaenoic Acids
  • Eicosapentaenoic Acid